MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans

    E. Uc, C. Weber, M. Lenz, J. Dawson (Iowa City, USA)

    Objective: 1-Comparing the risk of prodromal PD between AO exposed veterans (AOEV) and non-AO exposed veterans without PD (Controls) in a Veterans Affairs (VA) hospital…
  • 2025 International Congress

    Long-Term Effects of Telerehabilitation on Functional Mobility and Quality of Life in Parkinson’s Disease: A Systematic Review

    A. Elsayed, D. W. Ismail, H. Elshazly, Y. M.HUSSEINY, S. Elrobeigi, Y. Hamdi, M. M. Elsayed (Mansoura, Egypt)

    Objective: To evaluate the long-term effects of telerehabilitation on functional mobility and quality of life (QoL) in individuals with Parkinson’s disease (PD) and determine its…
  • 2025 International Congress

    Morbidity and Mortality Associated with Aspiration Pneumonia: Nationwide Trends in Inpatient Therapy Utilization in Parkinson’s Disease Hospitalization

    T. Mehta, H. Kamo, R. Burke, M. Rem, M. Okun, C. Hess (Gainesville, USA)

    Objective: To characterize inpatient therapy utilization and the impact of aspiration pneumonia (AP) on morbidity, mortality, and outcomes in hospitalized Parkinson’s disease (PD) patients. Background:…
  • 2025 International Congress

    The Role of Knowledgeable Informants in the Early Detection of Parkinson’s Disease

    E. Trinh, K. Harrison, M. Korell, C. Meng, E. Brown, K. Comyns, X. Chen, M. Bock, L. Racelo, G. Stebbins, C. Tanner (San Francisco, USA)

    Objective: To investigate the reporting of changes observed by Knowledgeable Informants (KIs) and people with Parkinson’s disease (PwPD) prior to a Parkinson’s disease (PD) diagnosis.…
  • 2025 International Congress

    Pesticide Exposure and Parkinson’s Disease Motor Subtype

    D. Thordarson, J. Bronstein, A. Keener, B. Ritz, K. Paul (Los Angeles, USA)

    Objective: The present study aims to investigate the link between Parkinson’s disease (PD) motor subtype and PD-relevant pesticide exposures. Background: PD is a neurodegenerative disorder…
  • 2025 International Congress

    Negative Correlation between Apathy and Executive Functioning in Patients with Idiopathic Parkinson’s Disease without Dementia.

    P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospinta-Otalvaro, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, A. Maria Valencia-Orjuela (Cali, Colombia)

    Objective: To establish the impact of apathy on executive functioning in patients with IPDWD. Background: Executive Functioning is one of the domains of neurocognitive functioning…
  • 2025 International Congress

    Distinct roles of PARK2, PINK1, and LRRK2 in neuroinflammation: resistance and susceptibility in immune-mediated mouse models

    D. Cossu, H. Okada, S. Noda, Y. Tomizawa, S. Ueno, L. Sechi, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate the impact of PARK2, PINK1, and LRRK2 deficiency on neuroinflammation in aging, using immune-mediated mouse models. Background: Emerging evidence links mitophagy-related genes, including PARK2 (PARKIN), PINK1, and LRRK2, to immune…
  • 2025 International Congress

    Neuroprotective Effects of ATP6V0C Overexpression in PFF Model Mice

    Y. Wang, Y. Xia, L. Kou, T. Wang (wuhan, China)

    Objective: Elucidating the role of lysosomal dysfunction due to altered stability and expression levels of V-type proton subunit ATP6V0C in the degradation and propagation of…
  • 2025 International Congress

    Decreased cholinergic activity in specific brain regions associated with slower lower limb visual choice reaction time in Parkinson’s disease: A [18F]-FEOBV PET study

    P. Kanel, G. Carli, J. Barr, F. Michalakis, S. Roytman, R. Vangel, P. Scott, C. Pongmala, R. Albin, N. Bohnen (Ann. Arbor, USA)

    Objective: To investigate the relationship between cholinergic system changes, as measured by vesicular acetylcholine transporters (VAChT) [18F] fluoroethoxybenzovesamicol ([18F] FEOBV) binding in PET, and cognitive performance, measured as…
  • 2025 International Congress

    Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner

    E. Luna, K. Cousins, S. Emrani, K. Luk, V. Lee, E. Lee, D. Weintraub, S. Xie, A. Chen-Plotkin, F. Bennett, D. Irwin (Philadelphia, USA)

    Objective: The objective of this study is to examine the sub-regional differences in neuroinflammation (NI) in response to Lewy pathology (LP) within the hippocampus of…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley